How does Restasis compare to Cequa or other alternatives for treating chronic dry eye?

Restasis and Cequa both contain cyclosporine and are FDA-approved for treating chronic dry eye, but differ slightly in formulation, delivery, and availability. Consult your eye care provider to determine which option best fits your needs.

Overview

Chronic dry eye can disrupt daily life, causing irritation, blurry vision, or discomfort. People researching treatment options often compare Restasis to Cequa and other therapies to understand their differences.

• Restasis and Cequa share the same active ingredient but use different delivery technologies.
• Cost, tolerability, and prescription access may also influence choice.
• This overview helps clarify how Restasis works and where it stands in the range of options.

Next, let’s look at how Restasis works to treat dry eye disease.

Detailed Information

How it works

Restasis may help by increasing tear production in patients whose tear production is suppressed due to inflammation. According to Drugs.com, cyclosporine—its active ingredient—works as an immunomodulator that targets inflammation in the lacrimal glands, potentially improving tear function over time.

Clinical applications

Restasis is primarily used to manage chronic dry eye (also known as keratoconjunctivitis sicca) in individuals who fail to produce enough tears naturally. It is often prescribed when artificial tears aren’t sufficient. Cequa, which also contains cyclosporine, is another prescription option with a different delivery vehicle. Other alternatives include over-the-counter lubricants and newer therapies, depending on clinical need.

Safety and Effectiveness

Safety profile

According to the official Israeli Ministry of Health leaflet, the most common side effects of Restasis include a burning sensation in the eyes, eye redness, and discharge. As with any prescription, users should consult their doctor before starting therapy to weigh benefits and risks.

FDA approval and indications

Restasis is FDA-approved to increase tear production in patients with chronic dry eye caused by eye inflammation. It should only be used under medical supervision and is not intended for immediate symptom relief.

Access and Availability

How to obtain safely

IsraelPharm offers international access to Restasis at competitive rates through a licensed pharmacy. Patients should speak with their healthcare provider to ensure it’s appropriate and obtain a valid prescription before ordering.

Key Takeaways

• Restasis and Cequa both use cyclosporine to address inflammation-related tear deficiency.
• They differ in formulation and delivery systems, which may affect tolerability and onset.
• Side effects may include burning or redness when applied.
• Restasis is FDA-approved and available with a prescription from licensed pharmacies like IsraelPharm.
• Clinical guidance is essential to choose the most suitable dry eye treatment.

FAQ

Can I use Restasis every day?

Yes, Restasis is typically used twice daily in each eye as prescribed. Follow your doctor’s instructions exactly for best results.

Is Cequa more effective than Restasis?

Both contain cyclosporine but use different delivery technologies. Some users may tolerate one better than the other; effectiveness varies by individual.

How long does it take for Restasis to work?

According to IsraelPharm’s blog on dry eye, some patients notice improvement in tear production after several weeks, but it may take 3–6 months for full benefits to appear.

Are there over-the-counter alternatives to Restasis?

While artificial tears and eye lubricants can relieve symptoms, they don’t address the underlying inflammation like Restasis or Cequa. They may be used alone or alongside prescription treatments.

How much does Restasis cost through IsraelPharm?

Prices can vary depending on quantity and shipping. Visit IsraelPharm’s Restasis product page or contact them directly for current pricing and order support.